Invention Grant
US09198951B2 Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure
有权
治疗剂量的神经调节蛋白或其后续剂量用于治疗或预防心力衰竭
- Patent Title: Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure
- Patent Title (中): 治疗剂量的神经调节蛋白或其后续剂量用于治疗或预防心力衰竭
-
Application No.: US13904654Application Date: 2013-05-29
-
Publication No.: US09198951B2Publication Date: 2015-12-01
- Inventor: Anthony O. Caggiano , Anindita Ganguly , Jennifer Iaci , Tom Parry
- Applicant: Acorda Therapeutics, Inc.
- Applicant Address: US NY Ardsley
- Assignee: Acorda Therapeutics, Inc.
- Current Assignee: Acorda Therapeutics, Inc.
- Current Assignee Address: US NY Ardsley
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Main IPC: A61K38/18
- IPC: A61K38/18 ; C07K14/475
Abstract:
The invention relates to treatment of heart failure in a mammal. Accordingly, the invention is directed to establishing a dosing regimen whereby the therapeutic benefits conferred by administration of a neuregulin such as glial growth factor 2 (GGF2) or a subsequence thereof are maintained and/or enhanced, while concomitantly minimizing any potential side effects.
Public/Granted literature
Information query
IPC分类:
